Ronald Brown, MD
Internal Medicine · Cookson, OKNPI 1801846779
Payments from drug & device makers
Across 233 payments — averaging $23.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- Smith+Nephew$929
- Organogenesis Inc.$529
- Paratek Pharmaceuticals, Inc.$501
- Next Science LLC$319
- Mimedx Group, Inc.$311
- plus $1K from 19 others
What the payments were for
- Food & beverage$5,473100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 43 | $1,738 |
| Smith+Nephew | 54 | $929 |
| Organogenesis Inc. | 23 | $529 |
| Paratek Pharmaceuticals, Inc. | 29 | $501 |
| Next Science LLC | 16 | $319 |
| Mimedx Group, Inc. | 17 | $311 |
| Osiris Therapeutics Inc. | 11 | $220 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $172 |
| KCI USA, Inc. | 8 | $155 |
| Solventum Corporation | 4 | $101 |
| AbbVie | 5 | $85 |
| Inari Medical, Inc. | 3 | $77 |
| Melinta Therapeutics, LLC | 4 | $75 |
| Medline Industries LP | 3 | $57 |
| Reapplix Inc. | 2 | $31 |
| Apria Healthcare LLC | 1 | $28 |
| Nabriva Therapeutics, PLC | 1 | $20 |
| Hydrofera LLC | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Polymedics Innovations Inc. | 1 | $17 |
| Reprise Biomedical, Inc. | 1 | $17 |
| Kerecis Limited | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| Convatec Inc. | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,473 in reported general payments places this provider in the 85th percentile of 840 internal medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 57 | $1,353 |
| Cephalexin | 116 | $1,125 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 71 | $1,050 |
| Gentamicin Sulfate | 25 | $687 |
| Mupirocin | 74 | $682 |
| Minocycline Hcl | 69 | $597 |
| Ciprofloxacin Hcl | 61 | $554 |
| Doxycycline Monohydrate | 32 | $509 |
| Clindamycin Hcl | 36 | $350 |
| Levofloxacin | 35 | $252 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $239 |
| Metronidazole | 17 | $224 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Cookson
- Al-Ola AbdallahTulsa$10.1M
- Melita TateTulsa$9.1M
- Sagila GeorgeOklahoma City$1.8M
- Ryan MorganOklahoma City$775K
- Renae MayerTulsa$766K
- George FreemanIdabel$742K
- Elise WiesnerNorman$584K
- Steve EgwuonwuLawton$464K
- Mousumi SomTulsa$391K
- Jesse RichardsTulsa$279K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.